LB Pharmaceuticals News and Activities

Acquisition, funding and merger involving LB Pharmaceuticals.

• LB Pharmaceuticals has just announced a $100 Million fundraising (posted on February 6 2026).
• LB Pharmaceuticals has just announced a $75 Million fundraising (posted on June 28 2024).

View the org chart displaying its 21 main executives

Most searched biographies at LB Pharmaceuticals

• Heather Turner, Chief Executive Officer
• Robert Lenz, Director
• Rebecca Luse, Director

Popular executive movements at LB Pharmaceuticals

• Robert Lenz has joined the company as Director  (posted on March 10 2026).
• Minako Pazdera has joined the company as General Counsel  (posted on January 21 2026).
• Kathy Dorsey has joined the company as Senior Director of Clinical Operations  (posted on January 21 2026).

Click here to view some more movements at LB Pharmaceuticals

Create your alert
to follow the executive moves at LB Pharmaceuticals.

LB Pharmaceuticals has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by LB Pharmaceuticals

Social media about LB Pharmaceuticals

• LB Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• LB Pharmaceuticals on LinkedIn, X (Twitter) & YouTube